Chairpersons
Novo Nordisk's Boardroom Drama: Implications of Foundation's Power Play
Novo Nordisk, a Danish pharmaceutical company behind Ozempic and Wegovy, is undergoing a significant transformation as its chairman, Helge Lund, and six other board directors stepped down amid a dispute with the company's top shareholder, the Novo Nordisk Foundation. The foundation, which owns 77% of voting rights, has